NCI Correlative Studies with Specimens from Multi-Site Trials Grant (R21)

Opportunity ID: 44073

General Information

Document Type: Grants Notice
Funding Opportunity Number: PA-08-133
Funding Opportunity Title: Correlative Studies with Specimens from Multi-Site Trials (R21)
Opportunity Category: Discretionary
Opportunity Category Explanation:
Funding Instrument Type: Grant
Category of Funding Activity: Education
Health
Category Explanation:
Expected Number of Awards:
Assistance Listings: 93.393 — Cancer Cause and Prevention Research
Cost Sharing or Matching Requirement: No
Version: Synopsis 1
Posted Date: Dec 05, 2008
Last Updated Date:
Original Closing Date for Applications: May 07, 2011
Current Closing Date for Applications: May 07, 2011
Archive Date: Jun 07, 2011
Estimated Total Program Funding:
Award Ceiling: $200,000
Award Floor:

Eligibility

Eligible Applicants: Public and State controlled institutions of higher education
Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Private institutions of higher education
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
Others (see text field entitled “Additional Information on Eligibility” for clarification)
For profit organizations other than small businesses
Small businesses
State governments
Additional Information on Eligibility: Other Eligible Applicants include the following:
Eligible Agencies of the Federal Government
Non-domestic (non-U.S.) Entities (Foreign Organizations)
Regional Organizations
U.S. Territory or Possession

Additional Information

Agency Name: National Institutes of Health
Description: -Purpose. This Funding Opportunity Announcement (FOA) is intended to support translational correlative studies that utilize annotated tumor and/or other biospecimens collected during large-scale multi-institutional clinical and/or prevention trials, respectively. The Cancer Therapy Evaluation Program (CTEP), the Cancer Diagnosis Program (CDP), and the Cancer Biomarkers Research Group (CBRG) of the NCI are cooperatively sponsoring this FOA with the overarching goal to facilitate predictions of responses to current interventions, and inspire future development of improved therapeutic and preventive strategies. Projects proposed in response to this FOA should address the correlations between intervention outcomes and cancer patients disease characteristics determined at various cellular/molecular levels. For example, disease progression patterns may be correlated with tumor genotypic and/or phenotypic profiles (at the levels of the genome, epigenome, gene expression and/or protein and non-protein molecular markers. This FOA will only support studies that use tumor specimens linked to specific interventions/trials. To be able to achieve these translational goals, the proposed projects are expected to rely on interactions between basic researchers and clinical investigators, in order to improve future drug development and interventions.
-Mechanism of Support. This FOA utilizes the NIH Exploratory/Developmental Grant (R21) mechanism and runs in parallel with an FOA of identical scientific scope, PA-08-134, that solicits applications under the NIH Research Project Grant (R01) mechanism.
Link to Additional Information: http://grants.nih.gov/grants/guide/pa-files/PA-08-133.html
Grantor Contact Information: If you have difficulty accessing the full announcement electronically, please contact:

NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email:FBOWebmaster@OD.NIH.GOV

Version History

Version Modification Description Updated Date

Related Documents

Packages

Agency Contact Information: NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV

Email: FBOWebmaster@OD.NIH.GOV

Who Can Apply: Organization Applicants

Assistance Listing Number Competition ID Competition Title Opportunity Package ID Opening Date Closing Date Actions
ADOBE-FORMS-A Adobe-Forms-A PKG00009421 Dec 05, 2008 Feb 20, 2010 View
ADOBE-FORMS-B Use for submissions intended for due dates of January 25, 2010 and beyond PKG00015256 Dec 21, 2009 May 07, 2011 View

Package 1

Mandatory forms

44073 RR_SF424-1.1.pdf

44073 RR_KeyPersonExpanded-1.1.pdf

44073 RR_OtherProjectInfo-1.1.pdf

44073 RR_PerformanceSite-1.1.pdf

44073 PHS398_CoverPageSupplement-1.1.pdf

44073 PHS398_ResearchPlan-1.1.pdf

44073 PHS398_Checklist-1.1.pdf

Optional forms

44073 PHS398_CoverLetter-1.1.pdf

44073 PHS398_ModularBudget-1.1.pdf

44073 RR_Budget-1.1.pdf

44073 RR_SubawardBudget-1.2.pdf

Package 2

Mandatory forms

44073 RR_SF424_1_2-1.2.pdf

44073 PerformanceSite_1_3-1.3.pdf

44073 RR_OtherProjectInfo_1_2-1.2.pdf

44073 RR_KeyPersonExpanded_1_2-1.2.pdf

44073 PHS398_CoverPageSupplement_1_4-1.4.pdf

44073 PHS398_ResearchPlan_1_3-1.3.pdf

44073 PHS398_Checklist_1_3-1.3.pdf

Optional forms

44073 PHS_CoverLetter_1_2-1.2.pdf

44073 PHS398_ModularBudget-1.1.pdf

44073 RR_Budget-1.1.pdf

44073 RR_SubawardBudget-1.2.pdf


Comments

Leave a Reply

Your email address will not be published. Required fields are marked *